Navigation Links
Relsys International Launches the Pharmacovigilance Integrated Services Offering and Significantly Expands Project Delivery Capabilities
Date:12/8/2008

IRVINE, Calif., Dec. 8 /PRNewswire/ -- Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions, announces the launch of its Integrated Services Offering for pharmacovigilance as well as significant growth of its Global Professional Services (GPS) organization.

In 2008, Relsys has delivered numerous Argus Safety(TM) upgrade projects, even as it continues to add new system implementations to its portfolio. Chris Jabbal, Chief Services Officer for Relsys, commented: "This year, our GPS organization has increased the number of projects delivered by more than 300% over 2007, with several more projects due to be completed before the end of the year." New safety database implementations in 2008 have included at least three Top 20 pharma companies, as well numerous smaller and mid-sized companies. Jabbal continued: "We have proactively scaled our professional services organization to address the growth in our project portfolio. Our team has doubled in the past year, as we have hired numerous project managers, analysts and subject matter experts. The Relsys GPS team has the capacity to continue to deliver even more new projects in the future."

Relsys has also launched its Integrated Services Offering, focusing on delivering pharma projects on-time, to-plan and to-budget. Jabbal commented: "We have always been focused on delivering end-to-end drug safety solutions to address our clients' pharmacovigilance needs. Our primary vision is to effectively execute the delivery of the Integrated Services Offering to address pharma's pressing safety and risk management needs." To ensure successful execution, Relsys has also implemented a Services Quality Management System (SQMS) -- a quality assurance system for professional services with an explicit goal to increase standards of excellence. "We are very excited about the new programs -- they are an integral part of our vision to become a world-class services organization," said Jabbal.

Interested parties may learn more about the Integrated Service Offerings and SQMS by visiting http://www.relsys.net/services or by contacting us at info@relsys.net.

About Relsys International

Relsys International provides the industry-leading Argus suite, a complete systems solution for Drug Safety, Pharmacovigilance and Risk Management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's widely-used drug safety and adverse event reporting software. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit http://www.relsys.net, or call +1 949-453-1715.


'/>"/>
SOURCE Relsys International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
2. M. D. Anderson to hold first international conference on inflammatory breast cancer
3. Ramsey, N.J. Therapists Lectures to International Medical Professionals & Provides Treatment to Professional Athletes at Home and Abroad
4. NSF International Offers Answers to Rising Toy Safety Concerns
5. PRA International Expands European Presence With Opening of Munich Office
6. International study supports new standard of treatment for women with advanced ovarian cancer
7. UH Rainbow Babies and Childrens Hospital gains international recognition for ECMO treatment
8. Mercy Ships Recognizes International Day of Disabled Persons
9. President George W. Bush Receives International Medal of PEACE That Coincides With PEPFAR Milestone on World Aids Day:
10. PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
11. International Medical Corps Launches Online Catalog Offering Gifts That Save the Lives of Those in Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
(Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
(Date:6/25/2017)... , ... June 25, 2017 , ... June is Men’s Health Month and ... most common cancer among men in the U.S. and the third most common cause of ... estimated that one man in seven will be diagnosed with prostate cancer during his lifetime. ...
(Date:6/24/2017)... Erie, PA (PRWEB) , ... June 24, 2017 ... ... was held in Erie, PA at the Sheraton Erie Bayfront and Erie Convention ... hands-on evidence based medicine experience, exhibits, a student quiz bowl, award and scholarship ...
(Date:6/24/2017)... ... ... The weather is heating up and the days are getting longer, providing the ... the summer months provide more than warmer temperatures that are perfect for BBQ’s and ... from direct exposure to the sun. When it comes to the security of homes ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
Breaking Medicine Technology: